Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) will unveil its latest earnings on Wednesday, November 7, 2012. Chelsea Therapeutics International is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of innovative pharmaceutical products.
Chelsea Therapeutics International Ltd. Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for a loss of 11 cents per share, a narrower loss from the year-earlier quarter net loss of 18 cents. During the past three months, the average estimate has moved up from a loss of 17 cents. Between one and three months ago, the average estimate moved up. It has been unchanged at a loss of 11 cents during the last month.
Past Earnings Performance: The company topped forecasts last quarter after being in line with estimates the quarter prior. In the second quarter, it reported net loss of 12 cents per share versus a mean estimate of 19 cents. Two quarters ago, it reported a loss of 23 cents per share.
Earnings season is back and more important than ever. Get our newest CHEAT SHEET stock picks now
A Look Back: In the second quarter, the company’s loss narrowed to a loss of $7.9 million (12 cents a share) from a loss of $13.3 million (21 cents) a year earlier, beating analyst expectations. Revenue remained steady at $0.0.
Balance Sheet Analysis: The company’s current ratio of assets to liabilities came in at 4.83 last quarter. Having a ratio above 2:1 is usually considered a good indicator of a company’s liquidity and ability to meet creditor demands.
Analyst Ratings: There are mostly holds on the stock with three of five analysts surveyed giving that rating.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute — click here and get our CHEAT SHEET stock picks now.
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)
Don’t Miss These Additional Hot Stories:
Our 20-page proprietary analysis of Apple’s stock is ready. Click here and to get your Cheat Sheet report now.